News | Synnovation Therapeu

top of page

Latest News

Press Release

Synnovation Therapeutics Announces First Patient Dosed in Phase I Trial with SNV1521, a PARP1 Selective Inhibitor for the Treatment of Solid Tumors

March 11, 2024

View Press Release

Press Release

Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly Validated Disease Pathways

January 24, 2024

View Press Release

Article

Exclusive: Reid Huber reunites with former Incyte colleague Wenqing Yao, backs Synnovation with $102M for three trials

January 24, 2024

bottom of page